FDA Approves CLOZAPINE — Accord Healthcare Inc.

Accord Healthcare Inc. received FDA approval for generic CLOZAPINE, a move that expands supply for this crucial antipsychotic treatment and is expected to increase competitive pricing in the market. This ANDA approval offers a new bioequivalent alternative to the innovator brand, potentially filling unmet needs and intensifying competition among producers of the widely utilized medication.